Genetic Literacy ProjectCRISPR setback? Our immune system may attack the treatment used with the popular gene editorGenetic Literacy ProjectA new paper points to a previously unknown hurdle for scientists racing to develop therapies using the revolutio… Continue reading
CAR-T gene therapy treatments may fall short of corrective goals, requiring surgical gene editingGenetic Literacy ProjectFor decades, researchers, some physicians, and a few patients have had visions of treatments that would go in and fix diseases at t… Continue reading
Inquirer.netHow a blood test could predict the outcome of immunotherapy in cancer patientsInquirer.netResearchers from the University of Zurich in Switzerland have identified biomarkers in the blood that can predict whether cancer patients will respond… Continue reading
HealthlineResearchers Look at CAR-T Treatments for HIVHealthlineAccording to a study published last month in PLOS Pathogens, genetically engineered chimeric antigen receptor (CAR) T cells might be used to ultimately eradicate HIV. Scott Kitchen, PhD, a… Continue reading
HealthlineResearchers Look at CAR-T Treatments for HIVHealthlineAccording to a study published last month in PLOS Pathogens, genetically engineered chimeric antigen receptor (CAR) T cells might be used to ultimately eradicate HIV. Scott Kitchen, PhD, a… Continue reading
Stem Cell Combo Therapy Shows Efficacy in MS Mouse Model, Korean Study ShowsMultiple Sclerosis News TodaySpecifically, stem-cell treatment decreased inflammatory cell infiltration, mitigated the loss of myelin and promoted anti-inflammatory effects. … Continue reading
PMLiVECelixir cleared to start trial of stem cell therapy for heart failurePMLiVEUK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel – its stem cell-based therapy for heart failure – that could potentially support app… Continue reading
PMLiVECelixir cleared to start trial of stem cell therapy for heart failurePMLiVEUK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel – its stem cell-based therapy for heart failure – that could potentially support app… Continue reading